US2016024041A1PendingUtilityA1
PPARs AGONIST ACTIVITY ENHANCING DRUG
Est. expiryMar 27, 2032(~5.7 yrs left)· nominal 20-yr term from priority
Inventors:Munekazu Iinuma
A61P 3/10A61P 43/00A61P 9/12A61P 3/06A61P 3/04A61K 9/0053A61K 31/366A61P 3/00C07D 309/32
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A lifestyle disease improving drug that enhances PPARα, δ and γ agonist activities that includes a compound having the lactone structure in accordance with the chemical formula 6-alkyl-5,6-dihydro-2H-pyran-2-one, the alkyl containing 4, 5, or 6 carbons.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A compound having a lactone structure with the chemical formula:
2 . The compound of claim 1 , which enhances PPARα, δ and γ agonist activities.
3 . A lifestyle disease improving drug containing a compound having a chemical formula selected from the group consisting of:
wherein the lifestyle disease improving drug enhances PPARα, δ and γ agonist activities.
4 . The lifestyle disease improving drug of claim 3 , wherein the compound has the chemical formula:
5 . The lifestyle disease improving drug of claim 3 , wherein the compound has the chemical formula:
6 . The lifestyle disease improving drug of claim 3 , wherein the compound has the chemical formula:Join the waitlist — get patent alerts
Track US2016024041A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.